BRE-MI01

N/A

Report date: 2023/10/10 16:22:13

Base Information

Drug NameBRE-MI01
Drug Alias NameBRE-MI01
ClassificationBiologics
Mechanisms of ActionImmunosuppressantsExosome replacements
TargetsNot applicable
Therapy Area/IndicationsMyocardial Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBrexogen Inc
China Registration ClassN/A

Develop Information

Active CompaniesBrexogen Inc
Inactive CompaniesN/A
Active IndicationsMyocardial Infarction
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A